Soleo Health News
PRESS RELEASES AND MEDIA COVERAGE
May 13, 2022
Soleo Health Earns Five Stevie® Awards in 2022 American Business Awards®
April 20, 2022
Soleo Health Earns Specialty Pharmacy Reaccreditation From URAC
March 7, 2022
Soleo Health’s Atlanta Pharmacy Relocates to Meet Growing Patient Demand
January 26, 2022: Access Market Intelligence
argenx SE Selects Soleo Health as a Limited Distribution Partner for VYVGART
January 24, 2022
Soleo Health Selected as Limited Distribution Partner for VYVGART™
January 11, 2022
Soleo Health to Administer OXLUMO™ for the Treatment of Primary Hyperoxaluria Type 1
October 29, 2021: HME News
COVID Infusion Therapy Shifts To The Home
October 5, 2021
Soleo Health Philadelphia Earns Prestigious URAC Accreditation
September 21, 2021
Soleo Health Ranks Ninth on Dallas Business Journal’s Annual Middle Market 50 List; Marks Fourth Consecutive Year in Top Ten
September 20, 2021
Soleo Health Selected by Houston Methodist as Exclusive In-Home Provider of Infused Monoclonal Antibodies for Treatment of COVID-19
September 13, 2021
Soleo Health Unveils Therapeutic Care Management Center Dedicated to Thyroid Eye Disease Patients
September 9, 2021: AIS Health
Legislation Seeks to Change Medicare Home Infusion Policies
August 20, 2021: HME News
Infusion Stakeholders Take Fight Back To Congress
August 17, 2021
Soleo Health Strongly Supports Introduction of New Home Infusion Legislation
June 22, 2021
Soleo Health Names Becky Rand Vice President Business Development, Industry Relations
June 16, 2021
Soleo Health Selected As Specialty Pharmacy Partner For ADUHELM™, A New Treatment For Alzheimer's Disease
June 7, 2021
Soleo Health Phoenix Earns Prestigious URAC Accreditation
January 13, 2021
Soleo Health Enhances Capabilities of Soleo Connect®, Its Integrated Client Engagement Platform
January 7, 2021
Soleo Health Selected as Preferred Provider by Cigna’s eviCore healthcare for Specialty and Non-Specialty Infusion Services
December 21, 2020
Soleo Health Among First to Offer HEMA Biologics’ SEVENFACT®, a Newly Released Treatment for Bleeding Disorders
December 11, 2020
Mitsubishi Tanabe Pharma America Presents Real-World Experience Outcomes During IV Edaravone Treatment at Virtual 31st International Symposium on ALS/MND
November 2, 2020
Soleo Health Named Tier-One Preferred Provider by AscellaHealth in the Care and Management of Immunoglobulin Patients
October 9, 2020: HME News
Q&A: Monique Nelson wins ‘Hero’ award
October 5, 2020: Nasdaq
Exclusive Interview: The Motley Fool Sits Down With Citus Health CEO
September 30, 2020: PR Newswire
Mitsubishi Tanabe Pharma America Announces Presentations At Northeast Amyotrophic Lateral Sclerosis 19th Annual Meeting
September 30, 2020: HME News
Soleo Direct Uses Data to Keep Patients Home
September 22, 2020
Soleo Health’s Monique Nelson Wins Gold Stevie® Award in the 2020 International Business Awards®
September 14, 2020
Soleo Health Ranks 10th on Dallas Business Journal’s Annual Middle Market 50 List; Marks Third Consecutive Year in Top Ten
September 3, 2020
Soleo Health Debuts on Inc. Magazine's Inc. 5000
August 31, 2020
Soleo Health Named Preferred Provider by AscellaHealth in the Management of Its Hemophilia Patient Population
April 1, 2020
Soleo Health Selected By Grifols As Limited Drug Distribution Partner For XEMBIFY®
December 16, 2019: ALS New Today
Soleo and Mitsubishi Tanabe Enter Data-sharing Agreement for Radicava
December 9, 2019: AIS Health
Highmark’s New Hemophilia Initiative Aims to Improve Care, Reduce Costs
December 5, 2019
Soleo Health Provides Mitsubishi Tanabe Pharma America With Real-World Data For ALS Patients
November 27, 2019: HME News
Soleo Health Fills in Footprint
November 20, 2019: Hemophilia New Today
Insurer Highmark Partners With Soleo Health for Hemophilia Care, Management
November 20, 2019
Soleo Health Acquires Paragon Infusion Therapy, A Midwest Regional Specialty Infusion Provider
November 19, 2019
Soleo Health Selected By Highmark Inc. For New High-Performance Hemophilia Partnership
July 3, 2019: Bloomberg Law
Medicare Change on Home Drug Treatments Cuts Provider Pay 77%
July 1, 2019
Soleo Health Ranks Sixth On Dallas Business Journal’s Annual Middle Market 50 List
June 21, 2019: HME News
Soleo Sees Opportunity In Data
May 7, 2019
Soleo Health Names Craig Vollmer Chief Commercial Officer
February 25, 2019
Soleo Health Earns Accreditation From The Joint Commission and URAC
December 17, 2018
Soleo Health Opens Specialty Infusion Pharmacy Location In Birmingham, Alabama
November 6, 2018
Soleo Health Chosen To Distribute Specialty Drug By Shire
October 15, 2018
Soleo Health Appoints Ron Lindahl Chief Operating Officer
June 27, 2018
Soleo Health Selected By Genentech To Provide Two Limited Distribution Drugs
June 20, 2018
Soleo Health Ranks 8th On Dallas Business Journal's Annual Middle Market 50 List
May 7, 2018
Soleo Health Earns One Gold and Two Silver Stevie® Awards in 2018 American Business Awards®
March 26, 2018
Soleo Health Expands National Specialty Infusion Pharmacy Platform with Opening of Several Locations
February 9, 2018
Soleo Health Strongly Supports the Passing of the Bipartisan Budget Act of 2018
December 18, 2017
Home Infusion Stakeholders Rally for Passing of S. 1738 Before Year End
September 13, 2017
Soleo Health Introduces NutriSole™, An Innovative Specialty Parenteral Nutrition Program
May 23, 2017
Soleo Health Advocates for Thousands of Home Infusion Therapy Patients Affected by 21st Century Cures Act
March 25, 2016
Soleo Health Introduces SoleMetrics™ Evidenced Based Care Clinical Outcomes Program
October 22, 2015
Soleo Health Selected by Bio Products Laboratory (BPL) to Dispense Coagadex
August 31, 2015
Soleo Health Awarded The Joint Commission Gold Seal of Approval
June 17, 2015
Soleo Health Opens State-of-the-Art Pharmacy in Massachusetts
March 16, 2015
Soleo Health Donates Bicycles to Charities
December 1, 2014
Soleo Health Awarded URAC Specialty Pharmacy Accreditation
Legislative Updates
SOLEO HEALTH ADVOCATES FOR THOUSANDS OF HOME INFUSION THERAPY PATIENTS AFFECTED BY 21st CENTURY CURES ACT
Under the 21st Century Cures Act, certain previously covered home infusion service costs are no longer being reimbursed. While Congress remedied a reimbursement fix for home infusion patients and providers in 2021, the Cures Act created a four-year care gap (between 2017-2021) where patient access to life-sustaining home infusion therapy is threatened. Soleo Health is working with Congress to help fix the care gap.
For more information about Soleo Health’s legislative efforts, please review the following links:
Privacy Policy
CCPA Opt-Out
Notice of Non Discrimination
© 2020 Soleo Health.
All Rights Reserved.
